Summary
Elevance Health, Inc. (ELV) reported solid financial performance for the first quarter of 2018, with total revenues of $22.54 billion, a slight increase of 0.1% year-over-year. Net income saw a significant jump of 30.0% to $1.31 billion, leading to diluted earnings per share (EPS) of $4.99, up 33.8% from the prior year's first quarter. This strong profit growth was driven by higher operating results in both the Commercial & Specialty Business and Government Business segments, alongside a notable decrease in income tax expense, largely attributable to the Tax Cuts and Jobs Act of 2017 which lowered the federal corporate tax rate. Total medical membership slightly declined by 2.5% to 39.6 million, primarily due to reduced participation in ACA-compliant marketplaces and Medicaid business, though this was partially offset by growth in Medicare. The company's financial position remained robust, with total assets growing to $73.30 billion and total liabilities increasing to $46.29 billion, resulting in total shareholders' equity of $27.01 billion. Key financial activities during the quarter included strategic acquisitions within the Government Business segment, the repayment of debt, and continued share repurchases and dividend payments to shareholders. Despite a decrease in operating cash flow compared to the previous year, the company maintained sufficient liquidity and a stable debt-to-capital ratio. Investors should note the ongoing litigation and regulatory scrutiny, particularly concerning the Express Scripts PBM agreement and past data security incidents, which continue to present potential risks.
Financial Highlights
51 data points| Revenue | $22.54B |
| SG&A Expenses | $3.43B |
| Operating Income | $1.87B |
| Interest Expense | $184.00M |
| Net Income | $1.31B |
| EPS (Basic) | $5.13 |
| EPS (Diluted) | $4.99 |
| Shares Outstanding (Basic) | 255.80M |
| Shares Outstanding (Diluted) | 262.80M |
Key Highlights
- 1Net income increased by 30.0% to $1.31 billion for the first quarter of 2018, compared to the same period in 2017.
- 2Diluted EPS grew by 33.8% to $4.99, reflecting strong profitability.
- 3Operating revenue remained relatively stable, increasing by 0.1% to $22.34 billion, driven by modest growth in the Government Business segment.
- 4Total medical membership declined by 2.5% to 39.6 million, primarily due to reduced participation in ACA marketplaces and Medicaid business.
- 5The company completed strategic acquisitions in its Government Business segment (America's 1st Choice and HealthSun), indicating a focus on expanding Medicare Advantage offerings.
- 6Income tax expense decreased significantly by 7.4% due to the Tax Cuts and Jobs Act, contributing to improved net income.
- 7The company repurchased $394.7 million in common stock and paid $191.9 million in dividends during the quarter, demonstrating a commitment to shareholder returns.